Pathology · Female Genital and Breast Pathology

The most specific immunohistochemical marker to distinguish invasive lobular carcinoma from invasive ductal carcinoma of the breast is:

  • A Loss of E-cadherin expression
  • B ER (estrogen receptor) positivity
  • C HER2 overexpression
  • D Ki-67 proliferation index above 20%
Correct answer: A. Loss of E-cadherin expression

Explanation

Invasive lobular carcinoma characteristically loses E-cadherin expression due to CDH1 gene mutations/silencing, causing the classic 'single file' or 'Indian file' infiltrating pattern without cohesive gland formation. ER positivity is common to both types. HER2 amplification is typically negative in lobular carcinoma. E-cadherin loss is the defining molecular and IHC difference.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Female Genital and Breast Pathology MCQs

See all Female Genital and Breast Pathology MCQs →